Botulinum toxin has been approved by the Medicines Control Agency in the UK for the
treatment of the two conditions mentioned above and for muscle spasm (focal spasticity)
and sweaty armpits (axillary hyperhidrosis).
Vistabel is a different brand of botulinum toxin produced by Allergan, the manufacturers
of BOTOX. It is identical to BOTOX. The new name is used for the smaller package
approved in January 2006 in the UK for the cosmetic treatment of glabellar frown
BOTOX® is the formulation of botulinum toxin used at the Shropshire Skin Clinic (SSC)
for cosmetic purposes. In many countries this has received approval for cosmetic
injection of frown lines, but not in the UK as yet. Injection of Botox® in this way
is legal in the UK, but it is termed as unlicensed use.
Hyperactivity of the facial expression muscles often results in the development of
deep frown lines, forehead lines and/or crow's feet. These are the areas most commonly
treated with botulinum toxin. Some lines around the nose, mouth and chin as well
as muscle bands on the neck can also be treated. Injecting botulinum toxin into the
affected area temporarily paralyses the underlying muscles responsible for wrinkling,
giving the face a more relaxed and pleasant appearance. The wrinkles become smoother
or disappear altogether.
Botulinum toxin therapy cannot replace wrinkle correction methods such as filler
injections or laser peeling when these are necessary. The initial effects of treatment
become visible within 48 to 72 hours and the maximum effect is reached in about one
to two weeks. Facial expression will become more relaxed, but by no means mask like.
Our aim at the SSC is that the overall result is very natural.
The effect of treatment generally lasts for three to six months. Re treatment is
BOTOX® is based on the botulinum toxin and in cosmetic dermatology treatments it
is injected directly into overactive muscles. It has been safely and effectively
used for the treatment of eye squints (strabismus) and eyelid spasms (blepharospasm)
since the early eighties.